MedTrace Logo

Implementation of a System-level Tobacco Treatment Intervention

NCT02816697 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 263

Last updated 2026-04-16

No results posted yet for this study

Summary

The proposed study plans to adapt and study the implementation and effectiveness of integrating Clinical and Community Effort Against Secondhand smoke Exposure (CEASE) into the thoracic oncology setting using mixed methods.

Conditions

Interventions

OTHER

CEASE

* Clinical and Community Effort Against Secondhand Smoke Exposure (CEASE) * CEASE is a system-level intervention that integrates tobacco-use screening, cessation assistance, and referral to outside services into routine visits

OTHER

Usual Care Tobacco Treatment Services

Sponsors & Collaborators

Principal Investigators

  • Mary E Cooley, PhD, RN · Dana-Farber Cancer Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2022-12-01
Completion
2026-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02816697 on ClinicalTrials.gov